Loading…

Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection

The study objective was to determine whether there was an improvement in compliance with recommended Clostridium difficile infection (CDI) treatment after introduction of an institutional CDI bundle with daily antimicrobial stewardship assessment. This was a single-centre, quasi-experimental study e...

Full description

Saved in:
Bibliographic Details
Published in:Journal of antimicrobial chemotherapy 2016-03, Vol.71 (3), p.836-840
Main Authors: Brumley, Paul E, Malani, Anurag N, Kabara, Jared J, Pisani, Jennifer, Collins, Curtis D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c348t-6cbf7ed25df09107132bec1cbce931e454f92c48829196b5d0be39441fa416e23
cites cdi_FETCH-LOGICAL-c348t-6cbf7ed25df09107132bec1cbce931e454f92c48829196b5d0be39441fa416e23
container_end_page 840
container_issue 3
container_start_page 836
container_title Journal of antimicrobial chemotherapy
container_volume 71
creator Brumley, Paul E
Malani, Anurag N
Kabara, Jared J
Pisani, Jennifer
Collins, Curtis D
description The study objective was to determine whether there was an improvement in compliance with recommended Clostridium difficile infection (CDI) treatment after introduction of an institutional CDI bundle with daily antimicrobial stewardship assessment. This was a single-centre, quasi-experimental study evaluating compliance with an antimicrobial stewardship team-implemented care bundle in patients with CDI compared with historical controls. The primary outcome, compliance with overall bundle elements, was achieved when the following measures were accomplished: (i) appropriate CDI antimicrobial therapy based on the institutional treatment algorithm; (ii) discontinuation of acid-suppressant therapy in the absence of a pre-specified indication; and (iii) discontinuation of unnecessary antimicrobials. Secondary objectives were to evaluate the extent to which antimicrobial stewardship involvement affected treatment compliance and to assess trends in CDI clinical outcomes, such as mortality and readmission. One-hundred-and-sixty-nine patients were evaluated; 83 after implementation of the care bundle (bundle group) and 89 prior to bundle implementation (historical control group). Compliance with overall bundle endpoints was significantly higher in the bundle group versus the control group (81% versus 45%, P 
doi_str_mv 10.1093/jac/dkv404
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1780530447</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1780530447</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-6cbf7ed25df09107132bec1cbce931e454f92c48829196b5d0be39441fa416e23</originalsourceid><addsrcrecordid>eNqN0clKBDEQBuAgio6jFx9AAl5EaK0sne4cZXCDAS96btJZMGMvY5JWfHszjHrwJATq8vFTlR-hEwKXBCS7Wil9ZV7fOfAdNCNcQEFBkl00AwZlUfGSHaDDGFcAIEpR76MDKoQgTNIZam6cszrh0WE15Jd873UYW686HJP9UMHEF7_G7TSYzmI3BrxWydshRfzh0wtedGNMwRs_9dh457z22flhk-rH4QjtOdVFe_w95-j59uZpcV8sH-8eFtfLQjNep0Lo1lXW0NK4vDpUhNHWaqJbbSUjlpfcSap5XVNJpGhLA61lknPiFCfCUjZH59vcdRjfJhtT0_uobdepwY5TbEhVQ8mA8-ofVFApgJd1pmd_6GqcwpAP2ShZkZoDZHWxVfnjYgzWNevgexU-GwLNpqEmN9RsG8r49DtyantrfulPJewLxjaMwQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1769718400</pqid></control><display><type>article</type><title>Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection</title><source>Oxford Journals Online</source><creator>Brumley, Paul E ; Malani, Anurag N ; Kabara, Jared J ; Pisani, Jennifer ; Collins, Curtis D</creator><creatorcontrib>Brumley, Paul E ; Malani, Anurag N ; Kabara, Jared J ; Pisani, Jennifer ; Collins, Curtis D</creatorcontrib><description>The study objective was to determine whether there was an improvement in compliance with recommended Clostridium difficile infection (CDI) treatment after introduction of an institutional CDI bundle with daily antimicrobial stewardship assessment. This was a single-centre, quasi-experimental study evaluating compliance with an antimicrobial stewardship team-implemented care bundle in patients with CDI compared with historical controls. The primary outcome, compliance with overall bundle elements, was achieved when the following measures were accomplished: (i) appropriate CDI antimicrobial therapy based on the institutional treatment algorithm; (ii) discontinuation of acid-suppressant therapy in the absence of a pre-specified indication; and (iii) discontinuation of unnecessary antimicrobials. Secondary objectives were to evaluate the extent to which antimicrobial stewardship involvement affected treatment compliance and to assess trends in CDI clinical outcomes, such as mortality and readmission. One-hundred-and-sixty-nine patients were evaluated; 83 after implementation of the care bundle (bundle group) and 89 prior to bundle implementation (historical control group). Compliance with overall bundle endpoints was significantly higher in the bundle group versus the control group (81% versus 45%, P &lt; 0.001). Individual bundle components that were significantly improved in the bundle group were discontinuation of non-essential acid suppressants (90% versus 18%, P &lt; 0.001) and administration of appropriate CDI therapy (82% versus 64%, P &lt; 0.009). No significant differences were observed in overall or CDI-related mortality or readmissions, durations of therapy or reduction of non-essential concomitant antimicrobials. Introduction of an antimicrobial stewardship bundle for CDI significantly improved adherence to institutional treatment recommendations and overall management of patients with CDI.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/dkv404</identifier><identifier>PMID: 26661392</identifier><language>eng</language><publisher>England: Oxford Publishing Limited (England)</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents - therapeutic use ; Antimicrobial agents ; Bacterial infections ; Clostridium difficile ; Clostridium difficile - drug effects ; Clostridium difficile - isolation &amp; purification ; Clostridium Infections - chemically induced ; Clostridium Infections - drug therapy ; Clostridium Infections - microbiology ; Drug therapy ; Drug Utilization - standards ; Female ; Gram-positive bacteria ; Guideline Adherence ; Humans ; Male ; Middle Aged ; Non-Randomized Controlled Trials as Topic ; Organizational Policy ; Patient admissions ; Patient Readmission ; Survival Analysis ; Treatment Outcome ; Young Adult</subject><ispartof>Journal of antimicrobial chemotherapy, 2016-03, Vol.71 (3), p.836-840</ispartof><rights>The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</rights><rights>Copyright Oxford Publishing Limited(England) Mar 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c348t-6cbf7ed25df09107132bec1cbce931e454f92c48829196b5d0be39441fa416e23</citedby><cites>FETCH-LOGICAL-c348t-6cbf7ed25df09107132bec1cbce931e454f92c48829196b5d0be39441fa416e23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26661392$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brumley, Paul E</creatorcontrib><creatorcontrib>Malani, Anurag N</creatorcontrib><creatorcontrib>Kabara, Jared J</creatorcontrib><creatorcontrib>Pisani, Jennifer</creatorcontrib><creatorcontrib>Collins, Curtis D</creatorcontrib><title>Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>The study objective was to determine whether there was an improvement in compliance with recommended Clostridium difficile infection (CDI) treatment after introduction of an institutional CDI bundle with daily antimicrobial stewardship assessment. This was a single-centre, quasi-experimental study evaluating compliance with an antimicrobial stewardship team-implemented care bundle in patients with CDI compared with historical controls. The primary outcome, compliance with overall bundle elements, was achieved when the following measures were accomplished: (i) appropriate CDI antimicrobial therapy based on the institutional treatment algorithm; (ii) discontinuation of acid-suppressant therapy in the absence of a pre-specified indication; and (iii) discontinuation of unnecessary antimicrobials. Secondary objectives were to evaluate the extent to which antimicrobial stewardship involvement affected treatment compliance and to assess trends in CDI clinical outcomes, such as mortality and readmission. One-hundred-and-sixty-nine patients were evaluated; 83 after implementation of the care bundle (bundle group) and 89 prior to bundle implementation (historical control group). Compliance with overall bundle endpoints was significantly higher in the bundle group versus the control group (81% versus 45%, P &lt; 0.001). Individual bundle components that were significantly improved in the bundle group were discontinuation of non-essential acid suppressants (90% versus 18%, P &lt; 0.001) and administration of appropriate CDI therapy (82% versus 64%, P &lt; 0.009). No significant differences were observed in overall or CDI-related mortality or readmissions, durations of therapy or reduction of non-essential concomitant antimicrobials. Introduction of an antimicrobial stewardship bundle for CDI significantly improved adherence to institutional treatment recommendations and overall management of patients with CDI.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antimicrobial agents</subject><subject>Bacterial infections</subject><subject>Clostridium difficile</subject><subject>Clostridium difficile - drug effects</subject><subject>Clostridium difficile - isolation &amp; purification</subject><subject>Clostridium Infections - chemically induced</subject><subject>Clostridium Infections - drug therapy</subject><subject>Clostridium Infections - microbiology</subject><subject>Drug therapy</subject><subject>Drug Utilization - standards</subject><subject>Female</subject><subject>Gram-positive bacteria</subject><subject>Guideline Adherence</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Non-Randomized Controlled Trials as Topic</subject><subject>Organizational Policy</subject><subject>Patient admissions</subject><subject>Patient Readmission</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqN0clKBDEQBuAgio6jFx9AAl5EaK0sne4cZXCDAS96btJZMGMvY5JWfHszjHrwJATq8vFTlR-hEwKXBCS7Wil9ZV7fOfAdNCNcQEFBkl00AwZlUfGSHaDDGFcAIEpR76MDKoQgTNIZam6cszrh0WE15Jd873UYW686HJP9UMHEF7_G7TSYzmI3BrxWydshRfzh0wtedGNMwRs_9dh457z22flhk-rH4QjtOdVFe_w95-j59uZpcV8sH-8eFtfLQjNep0Lo1lXW0NK4vDpUhNHWaqJbbSUjlpfcSap5XVNJpGhLA61lknPiFCfCUjZH59vcdRjfJhtT0_uobdepwY5TbEhVQ8mA8-ofVFApgJd1pmd_6GqcwpAP2ShZkZoDZHWxVfnjYgzWNevgexU-GwLNpqEmN9RsG8r49DtyantrfulPJewLxjaMwQ</recordid><startdate>201603</startdate><enddate>201603</enddate><creator>Brumley, Paul E</creator><creator>Malani, Anurag N</creator><creator>Kabara, Jared J</creator><creator>Pisani, Jennifer</creator><creator>Collins, Curtis D</creator><general>Oxford Publishing Limited (England)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201603</creationdate><title>Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection</title><author>Brumley, Paul E ; Malani, Anurag N ; Kabara, Jared J ; Pisani, Jennifer ; Collins, Curtis D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-6cbf7ed25df09107132bec1cbce931e454f92c48829196b5d0be39441fa416e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antimicrobial agents</topic><topic>Bacterial infections</topic><topic>Clostridium difficile</topic><topic>Clostridium difficile - drug effects</topic><topic>Clostridium difficile - isolation &amp; purification</topic><topic>Clostridium Infections - chemically induced</topic><topic>Clostridium Infections - drug therapy</topic><topic>Clostridium Infections - microbiology</topic><topic>Drug therapy</topic><topic>Drug Utilization - standards</topic><topic>Female</topic><topic>Gram-positive bacteria</topic><topic>Guideline Adherence</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Non-Randomized Controlled Trials as Topic</topic><topic>Organizational Policy</topic><topic>Patient admissions</topic><topic>Patient Readmission</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brumley, Paul E</creatorcontrib><creatorcontrib>Malani, Anurag N</creatorcontrib><creatorcontrib>Kabara, Jared J</creatorcontrib><creatorcontrib>Pisani, Jennifer</creatorcontrib><creatorcontrib>Collins, Curtis D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brumley, Paul E</au><au>Malani, Anurag N</au><au>Kabara, Jared J</au><au>Pisani, Jennifer</au><au>Collins, Curtis D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>2016-03</date><risdate>2016</risdate><volume>71</volume><issue>3</issue><spage>836</spage><epage>840</epage><pages>836-840</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><abstract>The study objective was to determine whether there was an improvement in compliance with recommended Clostridium difficile infection (CDI) treatment after introduction of an institutional CDI bundle with daily antimicrobial stewardship assessment. This was a single-centre, quasi-experimental study evaluating compliance with an antimicrobial stewardship team-implemented care bundle in patients with CDI compared with historical controls. The primary outcome, compliance with overall bundle elements, was achieved when the following measures were accomplished: (i) appropriate CDI antimicrobial therapy based on the institutional treatment algorithm; (ii) discontinuation of acid-suppressant therapy in the absence of a pre-specified indication; and (iii) discontinuation of unnecessary antimicrobials. Secondary objectives were to evaluate the extent to which antimicrobial stewardship involvement affected treatment compliance and to assess trends in CDI clinical outcomes, such as mortality and readmission. One-hundred-and-sixty-nine patients were evaluated; 83 after implementation of the care bundle (bundle group) and 89 prior to bundle implementation (historical control group). Compliance with overall bundle endpoints was significantly higher in the bundle group versus the control group (81% versus 45%, P &lt; 0.001). Individual bundle components that were significantly improved in the bundle group were discontinuation of non-essential acid suppressants (90% versus 18%, P &lt; 0.001) and administration of appropriate CDI therapy (82% versus 64%, P &lt; 0.009). No significant differences were observed in overall or CDI-related mortality or readmissions, durations of therapy or reduction of non-essential concomitant antimicrobials. Introduction of an antimicrobial stewardship bundle for CDI significantly improved adherence to institutional treatment recommendations and overall management of patients with CDI.</abstract><cop>England</cop><pub>Oxford Publishing Limited (England)</pub><pmid>26661392</pmid><doi>10.1093/jac/dkv404</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 2016-03, Vol.71 (3), p.836-840
issn 0305-7453
1460-2091
language eng
recordid cdi_proquest_miscellaneous_1780530447
source Oxford Journals Online
subjects Adolescent
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents - therapeutic use
Antimicrobial agents
Bacterial infections
Clostridium difficile
Clostridium difficile - drug effects
Clostridium difficile - isolation & purification
Clostridium Infections - chemically induced
Clostridium Infections - drug therapy
Clostridium Infections - microbiology
Drug therapy
Drug Utilization - standards
Female
Gram-positive bacteria
Guideline Adherence
Humans
Male
Middle Aged
Non-Randomized Controlled Trials as Topic
Organizational Policy
Patient admissions
Patient Readmission
Survival Analysis
Treatment Outcome
Young Adult
title Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T12%3A19%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20an%20antimicrobial%20stewardship%20bundle%20for%20patients%20with%20Clostridium%20difficile%20infection&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Brumley,%20Paul%20E&rft.date=2016-03&rft.volume=71&rft.issue=3&rft.spage=836&rft.epage=840&rft.pages=836-840&rft.issn=0305-7453&rft.eissn=1460-2091&rft_id=info:doi/10.1093/jac/dkv404&rft_dat=%3Cproquest_cross%3E1780530447%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c348t-6cbf7ed25df09107132bec1cbce931e454f92c48829196b5d0be39441fa416e23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1769718400&rft_id=info:pmid/26661392&rfr_iscdi=true